UNITAID, Cipla Announce Agreement To Lower Cost Of Combination HIV Medication
Devex: Deal slashes drug price of 3 in 1 pill for people living with HIV
“…UNITAID and Indian pharmaceutical company CIPLA have entered into an agreement that allows the latter to slash the prices of its drug, Q-TIB, by 30 percent. This means that a person living with HIV will soon have access to a full month’s worth of the drug for only $1.99…” (Ravelo, 6/8).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.